Provided by Tiger Fintech (Singapore) Pte. Ltd.

Precision Drilling

47.78
+1.162.49%
Pre-market: 46.65-1.1300-2.37%04:17 EDT
Volume:203.82K
Turnover:9.61M
Market Cap:651.95M
PE:8.80
High:48.04
Open:46.18
Low:45.42
Close:46.62
Loading ...

Precision Drilling Highlights 2024 Achievements and Market Position

TIPRANKS
·
11 Mar

PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Mar

PDS Biotechnology’s Promising Phase 3 Trial and Strong Clinical Foundation Justify Buy Rating

TIPRANKS
·
07 Mar

PDS Biotechnology initiates VERSATILE-003 Phase 3 trial of Versamune HPV

TIPRANKS
·
07 Mar

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

GlobeNewswire
·
07 Mar

PDS' Step-Down Unit Forms New Entity in UAE

MT Newswires Live
·
07 Mar

Insider Buying Surge at PDS Biotechnology!

TIPRANKS
·
04 Mar

PDS Biotechnology Launches Registered Direct Offering; Shares Up

MT Newswires Live
·
28 Feb

PDS Biotech Secures Up to $22 Million in Direct Offering to Boost R&D

TIPRANKS
·
28 Feb

Precision Drilling Announces Details for 2025 Annual and Special Meeting

TIPRANKS
·
27 Feb

PDS Biotechnology prices 7.33M shares at $1.50 in registered direct offering

TIPRANKS
·
27 Feb

PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire
·
27 Feb

PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology

GlobeNewswire
·
26 Feb

PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Feb

Promising Efficacy of PDS Biotechnology’s Versamune Platform in Cervical Cancer Treatment Drives Buy Rating

TIPRANKS
·
25 Feb

PDS Biotechnology announces circulating tumor DNA results for Versamune HPV

TIPRANKS
·
24 Feb

PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research

GlobeNewswire
·
24 Feb

Returns On Capital Are Showing Encouraging Signs At Precision Drilling (TSE:PD)

Simply Wall St.
·
17 Feb

CIBC Remains a Buy on Precision Drilling (PDS)

TIPRANKS
·
15 Feb

Precision Drilling price target lowered to C$141 from C$146 at Raymond James

TIPRANKS
·
15 Feb